← All trials
NCT05734066
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 23, 2023
- Primary completion
- Dec 31, 2026
- Completion date
- Jun 30, 2027
- First posted
- Feb 17, 2023
- Last posted
- Nov 1, 2023
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jazz PharmaceuticalsLead sponsor
- Jazz PharmaceuticalsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.